Login / Signup

Fragment-Based Discovery of Novel VE-PTP Inhibitors Using Orthogonal Biophysical Techniques.

Wataru AsanoKenji YamanakaYasunori OharaToru UharaSatoki DoiTakuya OritaTomoko IwanagaTsuyoshi AdachiShingo FujiokaTatsuo AkakiKazutaka IkegashiraYoshiji Hantani
Published in: Biochemistry (2023)
Tyrosine phosphorylation is an essential post-translational modification that regulates various biological events and is implicated in many diseases including cancer and atherosclerosis. Vascular endothelial protein tyrosine phosphatase (VE-PTP), which plays an important role in vascular homeostasis and angiogenesis, is therefore an attractive drug target for these diseases. However, there are still no drugs targeting PTP including VE-PTP. In this paper, we report the discovery of a novel VE-PTP inhibitor, Cpd-2, by fragment-based screening combining various biophysical techniques. Cpd-2 is the first VE-PTP inhibitor with a weakly acidic structure and high selectivity, unlike known strongly acidic inhibitors. We believe that this compound represents a new possibility for the development of bioavailable VE-PTP inhibitors.
Keyphrases
  • emergency department
  • small molecule
  • endothelial cells
  • high throughput
  • cardiovascular disease
  • ionic liquid
  • type diabetes
  • squamous cell carcinoma
  • drug induced
  • lymph node metastasis
  • electronic health record